Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about TLSA
Recent news which mentions TLSA
< Previous
1
2
3
4
Next >
Don't Get Caught In Equity Rally Hype: Lessons From 2023 To Remember In 2024
December 12, 2023
Tickers
AAPL
AMZN
FOMO
GOOGL
Tags
GOOGL
artificial intelligence
MSFT
From
Benzinga
Tiziana Expects To Start Enrolling Patients In Its Phase 2 Clinical Trial To Treat Secondary Progressive Multiple Sclerosis (SPMS) Using Its Novel Intranasal Monoclonal Antibody Foralumab
November 30, 2023
Tickers
TLSA
Tags
Biotech
Partner Content
Penny Stocks
From
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
October 19, 2023
Tickers
AIP
ATNF
BCEL
BSFC
Tags
TLSA
PRSO
CFRX
From
InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 18, 2023
Tickers
AKAN
AKLI
BCEL
BPTH
Tags
SNES
BZI/TFM
HLTH
From
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
October 18, 2023
Tickers
ADN
ARAV
BCEL
BIOC
Tags
INBS
SPRC
MCOM
From
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 17, 2023
Tickers
ANEB
ASMB
BTTX
CELC
Tags
GLUE
EVLO
Movers
From
Benzinga
Tiziana To Announce Six-Month Human Safety And Biomarker Data At The ECTRIMS Annual Congress, Following-Up From Positive Outcomes Data Presented In June
October 12, 2023
Tickers
TLSA
Tags
General
Benzinga
TLSA
From
Benzinga
Tiziana Advances Phase 2 Site Selection For Its Lead Clinical Program In Non-Active Secondary Progressive Multiple Sclerosis (SPMS) And The Company Prepares For Six-Month Clinical Data Update
October 04, 2023
Tickers
RHHBY
SNY
TLSA
Tags
RHHBY
Tiziana Life Sciences
Market News
From
Benzinga
Tiziana Life Sciences Prepares To Advance Lead Intranasal Foralumab Program In First-Of-Its-Kind Phase 2a Clinical Trial for Non-Active SPMS Patients
September 27, 2023
Tickers
TLSA
Tags
Biotech
Penny Stocks
TLSA
From
Benzinga
Tesla Cybertruck To Be Used For Oracle's Next-Gen Police Car
September 20, 2023
Tickers
EVS
ORCL
TECH
TLSA
Tags
Tech
News
Market News
From
Benzinga
Tiziana Reveals Alzheimer's Research Milestone With PNAS Journal After FDA IND Green Light
September 12, 2023
Tickers
TLSA
Tags
Tiziana Life Sciences
Market News
Penny Stocks
From
Benzinga
Upcoming Phase 2 Data Expected For Longeveron's (NASDAQ: LGVN) Drug For the $4+ Billion Alzheimer's Sector – What To Look For
September 06, 2023
Tickers
ABOS
BIIB
LGVN
TLSA
Tags
Market News
General
LGVN
From
Benzinga
Tiziana's Intranasal Foralumab For Alzheimer's Treatment Gets FDA Nod For Phase 2 Trials Under Brigham And Women's Hospital Supervision
August 16, 2023
Tickers
TLSA
Tags
Benzinga
General
TLSA
From
Benzinga
Why PhenomeX Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
August 15, 2023
Tickers
AAMC
AEY
AKTX
AREN
Tags
CELL
Small Cap
FTCH
From
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
August 15, 2023
Tickers
BBLG
DCTH
DSGN
GLTO
Tags
GMVD
BZI/TFM
DSGN
From
Benzinga
Nvidia climbs, D.R. Horton gets a Buffett boost, and other stocks on the move
August 15, 2023
Tickers
AMC
BK
BRK-A
BRK-B
Tags
DSGN
DFS
BRK/A
From
MarketWatch
Why Tiziana Life Sciences Stock (TLSA) Is Climbing
August 15, 2023
Tickers
TLSA
Tags
why it's moving
Market News
News
From
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 15, 2023
Tickers
DCTH
DSGN
EVOK
GLTO
Tags
GLTO
TCRT
Movers
From
Benzinga
As Tiziana Life Sciences (NASDAQ: TLSA) Prepares For Phase 2 Trials, Have They Successfully Derisked Foralumab?
August 08, 2023
Tickers
BAYRY
SNY
TLSA
Tags
Tiziana Life Sciences
Market News
BAYRY
From
Benzinga
Tiziana (NASDAQ: TLSA) Continues The Fight Against Multiple Sclerosis, Will Announce 6-Month Results For Its Novel Treatment Soon
August 03, 2023
Tickers
SNY
TLSA
Tags
Partner Content
Penny Stocks
SNY
From
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 01, 2023
Tickers
ADMP
APLM
CMPX
MDXG
Tags
PEN
RVLP
Market News
From
Benzinga
Publications And Positive Data From Multiple Trials: Six Months In Review For Tiziana Life Sciences (NASDAQ: TLSA)
July 10, 2023
Tickers
SNY
TLSA
Tags
Market News
Tiziana Life Sciences
Biotech
From
Benzinga
Tiziana Life Sciences (NASDAQ: TLSA) Announces Positive Data In Its Secondary-Progressive Multiple Sclerosis Trial, What Could This Mean For The Company?
June 15, 2023
Tickers
PRVB
SNY
TLSA
Tags
SNY
Biotech
Partner Content
From
Benzinga
Tiziana's Foralumab Shown To Reduce Microglial Activation In MS Patients; Phase 2a Trial To Begin In Q3 2023
June 06, 2023
Tickers
TLSA
Tags
TLSA
General
Benzinga
From
Benzinga
Why GE HealthCare Technologies Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 25, 2023
Tickers
AAN
ACON
AGFY
ARWR
Tags
QTEK
MORF
SLGG
From
Benzinga
Tiziana Life Sciences To Submit Alzheimer's IND In Q2 2023, Seeks $3 Million From An Alzheimer's Foundation To Support Phase 2a Trial
April 21, 2023
Tickers
TLSA
Tags
TLSA
General
Benzinga
From
Benzinga
Tiziana Life Sciences Has Only Fully Human Anti-CD3 mAB In Clinical Studies, Could Be Poised To Improve Care For Patients With Severe Multiple Sclerosis
April 19, 2023
Tickers
EWTX
IPHA
PRVB
SGEN
Tags
Small Cap
Market News
EWTX
From
Benzinga
EXCLUSIVE: Tiziana Life Sciences Plans To Develop Multiple Sclerosis Hopeful For Long COVID Patients
April 13, 2023
Tickers
TLSA
Tags
TLSA
Benzinga
Exclusives
From
Benzinga
Treatments For Non-Active Secondary Progressive Multiple Sclerosis Remain Scarce – Tiziana Life Sciences' (NASDAQ: TLSA) First-In-Class Foralumab Is Showing Promise
April 12, 2023
Tickers
PRVB
SNY
TLSA
Tags
Penny Stocks
Partner Content
Biotech
From
Benzinga
Tiziana Receives Sign-Off From The FDA To Proceed With Phase 2 Clinical Trial In Patients With Non-Active Secondary Progressive Multiple Sclerosis (SPMS)
March 29, 2023
Tickers
TLSA
Tags
TLSA
General
Benzinga
From
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.